NeoGenomics is trading 4.04% up now at $18.02 as healthcare shares attract defensive buying while broader markets decline.
- Healthcare is up 1.28%, supported by rate uncertainty, elevated oil prices, and concerns about an AI-sector slowdown.
- NeoGenomics is participating in the Morgan Stanley Global Healthcare Conference from September 14β16; managementβs fireside chat is scheduled for September 15.
- No new company-specific announcement was identified.